Evidence map›Paper›PMID 30382552›Full record

ArticleEndocrine2019

Correction to: Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study.

Philippe Caron, Thierry Brue, Gérald Raverot, Antoine Tabarin, Anne Cailleux, Brigitte Delemer, Peggy Pierre Renoult, Aude Houchard, Fatine Elaraki, Philippe Chanson

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Endocrine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Philippe CaronHôpital Larrey, Toulouse, France. caron.p@chu-toulouse.fr.
Thierry BrueAix-Marseille University, INSERM, MMG, AP-HM, Hôpital de la Conception, CRMR HYPO, Marseille, France.
Gérald RaverotGroupement Hospitalier Est, Lyon, France.
Antoine TabarinHôpital Haut Lévêque-CHU de Bordeaux, Bordeaux, France.
Anne CailleuxRouen University Hospital, Endocrinology Unit, Inserm CIC-CRB 1404, F 76 000, Rouen, France.
Brigitte DelemerCHU de Reims, Reims, France.
Peggy Pierre RenoultCHU Bretonneau, Tours, France.
Aude HouchardIpsen Pharma, Boulogne-Billancourt, France.
Fatine ElarakiIpsen Pharma, Boulogne-Billancourt, France.
Philippe ChansonAssistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, F94275, Le Kremlin-Bicêtre, France.
Inserm · FRIpsen (France) · FRCentre Hospitalier Le Vinatier · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Reims · FRCentre Hospitalier Universitaire de Toulouse · FRCentre Hospitalier Universitaire de Tours · FRUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original version of this article unfortunately contained a mistake in corresponding author name as Philippe Chanson in the affiliation section.

Identifiers

PMID30382552
PMCPMC6329722
OpenAlexW2899296794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.